Asia scoliosis management market |2021 Analysis, Key Opportunities Major Players, Impact of COVID-19 and Size, Growth, Share, Regional Analysis With Global Industry Forecast To 2027, The ”Asia scoliosis management market” size is projected to reach USD 826.8 million by 2027, exhibiting a CAGR of 6.1% during the forecast period. Consistent prevalence of spinal deformities in Asian populations will be the leading trend shaping the growth trajectory of this market, postulates Fortune Business Insights™ in its report, titled “Asia Scoliosis Management Market Size, Share COVID-19 Impact Analysis, By Product (Orthosis System (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Lumbosarcal Orthosis (LSO), Thoracolumbosacral Orthosis (TLSO) and Spinal System), By Disease Type (Adolescent Idiopathic Scoliosis, Degenerative Scoliosis, and Congenital Scoliosis), By Age Group (Pediatrics, Adolescent, and Adults), By End User (Hospital ASCs, Clinics, and Others), and Country Forecast, 2020-2027”.

While no study has been conducted to identify the exact prevalence of scoliosis in Asia, several isolated researches have been undertaken to determine the incidence of the disease in different Asian countries. In Singapore, for example, prevalence of idiopathic scoliosis in 12- and 13-year-old female students was estimated to be 2.22% and 2.49%, respectively. In Taiwan, the incidence was 6.58% for a curve of 5 degrees and 2.4% for a curve of 10 degrees. A 2016 study conducted by the Ganga Hospital in Coimbatore, India found that 47% of the surveyed patients with congenital scoliosis suffered from intra-spinal anomalies, with tethered cord being the most common anomaly. Thus, the increasing prevalence of spinal deformities in Asia will stoke the adoption of scoliosis management technologies in the region in the coming years.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/sample/asia-scoliosis-management-market-104534

According to the report, the market value stood at USD 644.7 million in 2019. The report also offers the following:

• Unparalleled intelligence on the different market drivers, trends, and restraints;
• Valuable insights into the performance of all market segments;
• Comprehensive analysis of the leading players’ profiles and dominant strategies; and
• Detailed assessment of the impact of regional developments on market growth.

Restraining Factor

Weakening Revenues amid COVID-19 to Hamper Market Growth

The Asia scoliosis management market growth is likely to face a series of negative impacts as major medical devices companies have been suffering from unprecedented revenue shortfalls due to the coronavirus. In the early stages of the pandemic, Ireland-based Medtronic announced that its weekly sales plunged steeply as hospitals around the world put elective surgeries on hold. In March, for instance, the company’s sales in the US dipped by 60% while in China they fell by 40%. Similarly, Zimmer Biomet reported a massive decline of USD 1.78 billion in the first quarter of 2020 as 80% of the company’s revenues come from elective procedures. These companies are also confronting the sharp drop in non-essential surgeries worldwide. According to the University of Birmingham-led 120-country alliance called CovidSurg, nearly 28.4 million elective surgeries across the globe are likely to get canceled because of the coronavirus. The cumulative effect of these developments will inevitably hamper the companies’ investment plans in Asia, resulting in deflated market growth.

Asia Scoliosis Management Highlights of the Report:

1. Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
2. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Click here to get the short-term and long-term impact of COVID-19 on this market.

For more information visit : 

https://www.fortunebusinessinsights.com/asia-scoliosis-management-market-104534

Country Insights

China to Spearhead Market Development in Asia; Japan to Present Favorable Opportunities

Among countries, China is anticipated to dominate the Asia scoliosis management market share during the forecast period. The main reason behind China’s leading position in this market is the growing number of clinical trials being conducted in the country to develop sophisticated treatment options for spinal disorders. In Japan, rising incidence of scoliosis is expected to lucrative opportunities in the market, while in Singapore and South Korea increasing number of school screening programs to detect spinal deformities in children is likely to propel the market.